First National Trust Co Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• First National Trust Co has reduced its stake in UnitedHealth Group by 4.3%, owning 38,677 shares valued at approximately $20.26 million as of the latest SEC filing.
• UnitedHealth Group reported a quarterly EPS of $4.08, missing analysts' estimates of $5.16, and generating revenue of $111.62 billion during the period.
• The company's recent dividend payout increased to $2.21 per share, reflecting a positive change from the previous quarter's $2.10.

First National Trust Co cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.3% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 38,677 shares of the healthcare conglomerate's stock after selling 1,735 shares during the quarter. First National Trust Co's holdings in UnitedHealth Group were worth $20,257,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $28,000. Bayforest Capital Ltd grew its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares in the last quarter. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the fourth quarter worth $30,000. Finally, Kapitalo Investimentos Ltda bought a new position in UnitedHealth Group in the 4th quarter valued at $41,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director directly owned 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 over the last quarter. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $5.36 during trading on Wednesday, hitting $266.43. 22,302,965 shares of the stock traded hands, compared to its average volume of 13,886,933. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $241.69 billion, a price-to-earnings ratio of 11.54, a PEG ratio of 1.37 and a beta of 0.45. The firm's fifty day moving average is $298.96 and its 200-day moving average is $420.36. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $5.16 by ($1.08). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter last year, the company posted $6.80 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.32%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Robert W. Baird downgraded UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price objective for the company. in a research note on Wednesday, June 11th. Piper Sandler reduced their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday. Royal Bank Of Canada dropped their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday. Deutsche Bank Aktiengesellschaft dropped their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Finally, Mizuho dropped their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average target price of $378.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.